glp 1 y glp 2 The Discovery of GLP-2 and Development of Teduglutide for Short Bowel Syndrome Bispecific GLP-1/GLP-2 agonism in advanced

It is also noteworthy that some key studies [69, 72] were assessed as having a moderate risk of bias, which may affect the reliability and generalizability of their conclusions

Services Provided by Lambda: Study design Clinical conduct Protocol development PK Sampling Safety lab evaluations Bioanalysis Pharmacokinetic and Biostatistical analysis CSR preparation and Report Compilation Study Execution Overview Sample Size: 60 healthy adult subjects (Male and Female) 60 healthy adult subjects (Male and Female) Study Duration & Visits ~5 weeks study duration, with multiple outpatient visits for PK sampling ~5 weeks study duration, with multiple outpatient visits for PK sampling Key Safety Measures Implemented (in addition to routine safety parameters) In addition to standard laboratory assessments at screening, specific safety parameters serum lipase and amylase were also evaluated

Since GLP-1RAs simultaneously target IR, lipid profiles, and hepatic fat, they provide an actionable pharmacological tool for risk-forward preventive strategies (78, 83)

Were committed to supporting safe and responsible research, and we do not encourage use outside of controlled scientific settings